Earnings Reports
Filter News
Found 90,779 articles
-
Tigermed Reports Full Year 2023 Results
3/28/2024
Hangzhou Tigermed Consulting Co., Ltd., a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual results for the year ended December 31, 2023.
-
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
3/28/2024
Kodiak Sciences Inc., reported business highlights and financial results for the quarter and year ended December 31, 2023.
-
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
3/28/2024
DarioHealth Corp., a leader in the global digital health market, reported financial results for the fourth quarter 2023 and the full year 2023 and provided a corporate and commercial update.
-
Sequana Medical announces 2023 Full Year Results and 2024 Outlook
3/28/2024
Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces its financial results for the year ended 31 December 2023, and provides a business update and outlook for 2024 and beyond.
-
Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
3/28/2024
Medigene AG reported financial results for the fiscal year ended December 31, 2023, and provided a corporate update.
-
Theralase(R) Release's 4Q2023 Interim Financial Statements
3/27/2024
Theralase® Technologies Inc., a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds for the safe and effective destruction of various cancers, bacteria and viruses has released the Company's audited annual consolidated 2023 financial statements.
-
Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results
3/27/2024
Altimmune, Inc., a clinical-stage biopharmaceutical company, announced financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update.
-
EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
3/27/2024
EDAP TMS SA, the global leader in robotic energy-based therapies, reported unaudited financial results for the fourth quarter and full-year 2023.
-
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
3/27/2024
Precision BioSciences, Inc. announced financial results for the fourth quarter and fiscal year ended December 31, 2023 and provided a business update.
-
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
3/27/2024
Aeterna Zentaris Inc. reported its financial and operating results for the year ended December 31, 2023 and provided an update on the completion of enrollment for its ongoing Phase 3 safety and efficacy study AEZS-130-P02 evaluating macimorelin for the diagnosis of Childhood Onset Growth Hormone Deficiency.
-
BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024
3/27/2024
BiomX Inc. announced that the Company will host a conference call and a live audio webcast on Wednesday, April 3rd, 2024, at 8:00 a.m. ET, to report fourth quarter and full year 2023 financial results and a provide business update.
-
Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity
3/27/2024
Inhibikase Therapeutics, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023 and highlighted recent developments.
-
Varex Announces Closing of Revolving Credit Facility of $155 Million
3/27/2024
Varex Imaging Corporation announced it has entered into a senior secured revolving credit agreement for an initial aggregate principal amount of up to $155 million.
-
Dyadic to Attend Industry Events in April 2024
3/27/2024
Dyadic International, Inc. announced that its management will be attending the following industry events during the month of April 2024.
-
CARsgen Announced 2023 Annual Results
3/27/2024
CARsgen Therapeutics Holdings Limited, a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced its 2023 Annual Results.
-
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
3/27/2024
DURECT Corporation announced financial results for the fourth quarter and year ended December 31, 2023 and provided a business update.
-
Vicore Publishes the Annual Report for 2023
3/27/2024
Vicore Pharma Holding AB, unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists, announced the publication of the Annual Report for the financial year 2023.
-
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
3/27/2024
STRATA Skin Sciences, Inc. announced financial results for the fourth quarter and full-year ended December 31, 2023.
-
American Shared Hospital Services Reports Fourth Quarter 2023 Financial Results
3/27/2024
American Shared Hospital Services announced financial results for the fourth quarter ended December 31, 2023.
-
Abbott Hosts Conference Call for First-Quarter 2024 Earnings
3/27/2024
Abbott will announce its first-quarter 2024 financial results on Wednesday, April 17, before the market opens.